What We Do
Work With Us
Projects, Research & Case Studies
News & Events
Our Research – Healthy Ageing
Choice of empirical antibiotic therapy and adverse outcomes in older adults with suspected urinary tract infection: cohort study.
What do patients and family-caregivers value from hospice care? A systematic mixed studies review.
Media content analysis of the introduction of a “soft opt-out” system of organ donation in Wales 2015-17.
Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis.
The need for comparative data in spondyloarthritis.
Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis
Emergency Risk Communication: Lessons Learned from a Rapid Review of Recent Gray Literature on Ebola, Zika, and Yellow Fever
Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis
Health Impact and Economic value of meeting housing quality standards; a retrospective longitudinal data linkage study
Identifying patients with asthma-chronic obstructive pulmonary disease overlap syndrome using latent class analysis of electronic health record data: a study protocol
Emergency hospital admissions associated with a non-randomised housing intervention meeting national housing quality standards: a longitudinal data linkage study
Association between changes in lifestyle and all-cause mortality: the Health and Lifestyle Survey
Changes in Health Behaviours and Longevity
Socioeconomic inequality in medication persistence in
primary and secondary prevention of coronary heart disease – a population-wide electronic cohort study
EULAR recommendations for management of fibromyalgia
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries